Korea / Special Sits, Pairs, Index Rebalancing, Clepsydra Capital

Sanghyun Park

Korea / Special Sits, Pairs, Index Rebalancing

Clepsydra Capital

Investigate special situations, pairs, and index rebalancing trades in Korea.

Event-Driven

<h2>Swap overview</h2><p>This merger swap is very similar to the recent case of GS Retail &amp; GS Home Shopping. Green Cross Lab Cell will merge with Green Cross Cell through a stock swap. The Green Cross Cell shareholders will get 0.4023542 Green Cross Lab Cell shares for each Green Cross Cell share.</p><table class="table table-striped">
<colgroup>
<col width="300">
<col width="300">
</colgroup>
<tbody>
<tr><td colspan="2" rowspan="1" data-sheets-value='{"1":2,"2":"Swap overview"}'>Swap overview</td></tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Type"}'>Type</td>
<td data-sheets-value='{"1":2,"2":"Stock swap"}'>Stock swap</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Acquirer"}'>Acquirer</td>
<td data-sheets-value='{"1":2,"2":"Green Cross Lab Cell Corp (144510)"}'>Green Cross Lab Cell Corp (144510)</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Target company"}'>Target company</td>
<td data-sheets-value='{"1":2,"2":"Green Cross Cell Corp (031390)"}'>Green Cross Cell Corp (031390)</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Swap price for Green Cross Lab Cell"}'><strong>Swap price for Green Cross Lab Cell</strong></td>
<td data-sheets-value='{"1":3,"3":102882}'><strong>₩102,882</strong></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Swap price for Green Cross Cell"}'><strong>Swap price for Green Cross Cell</strong></td>
<td data-sheets-value='{"1":3,"3":41395}'><strong>₩41,395</strong></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Swap ratio"}'><strong>Swap ratio</strong></td>
<td data-sheets-value='{"1":3,"3":0.40235415330184093}' data-sheets-numberformat='{"1":2,"2":"#,##0.0000000","3":1}' data-sheets-formula="=R[-1]C[0]/R[-2]C[0]"><strong>0.4023542</strong></td>
</tr>
<tr><td colspan="2" rowspan="1" data-sheets-value='{"1":2,"2":"Source: DART"}'>Source: DART</td></tr>
</tbody>
</table><h2>Schedule</h2><p>The record date for securing voting rights at the general shareholders' meeting is August 2nd. The last day to secure the purchase right was yesterday. If you have purchased stocks by yesterday, you can exercise your stock purchase right by notifying your dissenting opinion between August 27 and September 13.</p><p>The exercise period of the stock appraisal right is from September 13th to October 4th. Trading of Green Cross Cell will be suspended from October 28th to November 11th, and new shares of Green Cross Lab Cell will be listed on November 12th.</p><table class="table table-striped">
<colgroup>
<col width="300">
<col width="300">
</colgroup>
<tbody>
<tr><td colspan="2" data-sheets-value='{"1":2,"2":"Schedule"}' data-sheets-note="Sang Hyun Park: We have to buy shares until BOD+1 to be eligible to receive stock purchase rights. We then have to notify our dissenting opinion until the end of dissenting opinion notice period.">Schedule</td></tr>
<tr>
<td><span data-sheets-value='{"1":2,"2":"Last day to own stock purchase rights"}' data-sheets-userformat='{"2":15041,"3":{"1":0},"9":0,"10":1,"12":0,"14":{"1":2,"2":4408131},"15":"Courier New","16":9}'>Last day to own stock purchase rights</span></td>
<td><span data-sheets-value='{"1":3,"3":44031}' data-sheets-userformat='{"2":15041,"3":{"1":5,"2":"yyyy. mm. dd","3":1},"9":2,"10":1,"12":0,"14":{"1":2,"2":4408131},"15":"Courier New","16":9}'>2020. 07. 19</span></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Record date of shareholder register"}'>Record date of the shareholder register</td>
<td data-sheets-value='{"1":3,"3":44045}' data-sheets-numberformat='{"1":5,"2":"yyyy. mm. dd","3":1}'>2020. 08. 02</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Dissenting opinion notice"}'><strong>Dissenting opinion notice</strong></td>
<td data-sheets-value='{"1":2,"2":"2020. 08. 27 ~ 09. 13"}'><strong>2020. 08. 27 ~ 09. 13</strong></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Shareholder meeting"}'><strong>Shareholder meeting</strong></td>
<td data-sheets-value='{"1":3,"3":44087}' data-sheets-numberformat='{"1":5,"2":"yyyy. mm. dd","3":1}'><strong>2020. 09. 13</strong></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Stock purchase right exercise"}'><strong>Stock purchase right exercise</strong></td>
<td data-sheets-value='{"1":2,"2":"2020. 09. 13 ~ 10. 04"}'><strong>2020. 09. 13 ~ 10. 04</strong></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Trade suspension (only Green Cross Cell)"}'><strong>Trade suspension (only Green Cross Cell)</strong></td>
<td data-sheets-value='{"1":2,"2":"2020. 10. 28 ~ 11. 11"}'><strong>2020. 10. 28 ~ 11. 11</strong></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Listing"}'>Listing</td>
<td data-sheets-value='{"1":3,"3":44147}' data-sheets-numberformat='{"1":5,"2":"yyyy. mm. dd","3":1}'>2020. 11. 12</td>
</tr>
<tr><td colspan="2" data-sheets-value='{"1":2,"2":"Source: DART"}'>Source: DART</td></tr>
</tbody>
</table><div>
<h2>Stock purchase rights</h2>
<p>The stock purchase cost ceiling is set at ₩150.0B combined for both. The exercise prices are currently 6.31% and 5.91% below the current share prices of GS Retail and GS Home Shopping. </p>
<table class="table table-striped">
<colgroup>
<col width="200">
<col width="200">
<col width="200">
</colgroup>
<tbody>
<tr>
<td data-sheets-value='{"1":2,"2":"Spread - stock purchase"}'>Spread - stock purchase</td>
<td style="text-align: center;" data-sheets-value='{"1":2,"2":"Green Cross Lab Cell Corp"}' data-sheets-formula="=R[-52]C[0]">Green Cross Lab Cell Corp</td>
<td style="text-align: center;" data-sheets-value='{"1":2,"2":"Green Cross Cell Corp"}' data-sheets-formula="=R[-49]C[-1]">Green Cross Cell Corp</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Current price"}'>Current price</td>
<td style="text-align: center;" data-sheets-value='{"1":3,"3":110200}' data-sheets-numberformat='{"1":2,"2":"[$₩-412]#,##0","3":1}' data-sheets-formula='=googlefinance(Terms!R[-52]C[0], "price")'>₩110,200</td>
<td style="text-align: center;" data-sheets-value='{"1":3,"3":43750}' data-sheets-numberformat='{"1":2,"2":"[$₩-412]#,##0","3":1}' data-sheets-formula='=googlefinance(Terms!R[-49]C[-1], "price")'>₩43,750</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Exercise price"}'><strong>Exercise price</strong></td>
<td style="text-align: center;" data-sheets-value='{"1":3,"3":103244}' data-sheets-numberformat='{"1":2,"2":"[$₩-412]#,##0","3":1}' data-sheets-formula="=R[-43]C[0]"><strong>₩103,244</strong></td>
<td style="text-align: center;" data-sheets-value='{"1":3,"3":41163}' data-sheets-numberformat='{"1":2,"2":"[$₩-412]#,##0","3":1}' data-sheets-formula="=R[-42]C[-1]"><strong>₩41,163</strong></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Premium/discount to the current price"}'><strong>Premium/discount to the current price</strong></td>
<td style="text-align: center;" data-sheets-value='{"1":3,"3":-0.06312159709618875}' data-sheets-numberformat='{"1":3,"2":"0.00%","3":1}' data-sheets-formula="=(R[-1]C[0]-R[-2]C[0])/R[-2]C[0]"><strong>-6.31%</strong></td>
<td style="text-align: center;" data-sheets-value='{"1":3,"3":-0.05913142857142857}' data-sheets-numberformat='{"1":3,"2":"0.00%","3":1}' data-sheets-formula="=(R[-1]C[0]-R[-2]C[0])/R[-2]C[0]"><strong>-5.91%</strong></td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Stock purchase ceiling condition"}'><strong>Stock purchase ceiling condition</strong></td>
<td colspan="2" rowspan="1" style="text-align: center;" data-sheets-value='{"1":3,"3":150}' data-sheets-numberformat='{"1":2,"2":"₩#,##0.0B"}' data-sheets-formula="=R[-46]C[0]"><strong>₩150.0B</strong></td>
</tr>
<tr><td colspan="3" rowspan="1" data-sheets-value='{"1":2,"2":"Source: DART &amp; KRX"}'>Source: DART &amp; KRX</td></tr>
</tbody>
</table>
<hr>
<h2>Price calculations</h2>
<p>Below is the calculation of swap prices and stock purchase rights exercise prices for reference.</p>
<table class="table table-striped">
<colgroup>
<col width="300">
<col width="100">
<col width="100">
<col width="100">
</colgroup>
<tbody>
<tr>
<td data-sheets-value='{"1":2,"2":"Swap prices"}'>Swap prices</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"Green Cross Lab Cell Corp"}' data-sheets-formula="=Terms!R[2]C[0]">Green Cross Lab Cell Corp</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"Green Cross Cell Corp"}' data-sheets-formula="=Terms!R[5]C[-1]">Green Cross Cell Corp</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"Note"}'>Note</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"1-month VWAP (June 16~July 15, 2021)"}'>1-month VWAP (June 16~July 15, 2021)</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":104418}'>₩104,418</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":41268}'>₩41,268</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"A"}'>A</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"1-week VWAP (July 9~July 15, 2021)"}'>1-week VWAP (July 9~July 15, 2021)</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":104029}'>₩104,029</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":41068}'>₩41,068</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"B"}'>B</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"1-day close (July 15, 2021)"}'>1-day close (July 15, 2021)</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":100200}'>₩100,200</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":41850}'>₩41,850</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"C"}'>C</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Swap price"}'><strong>Swap price</strong></td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":102882.33333333333}' data-sheets-formula="=sum(R[-3]C[0]:R[-1]C[0])/3"><strong>₩102,882</strong></td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":41395.333333333336}' data-sheets-formula="=sum(R[-3]C[0]:R[-1]C[0])/3"><strong>₩41,395</strong></td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"(A+B+C)/3"}'><strong>(A+B+C)/3</strong></td>
</tr>
<tr><td colspan="4" rowspan="1" data-sheets-value='{"1":2,"2":"Source: DART &amp; KRX"}'>Source: DART &amp; KRX</td></tr>
</tbody>
</table>
</div><table class="table table-striped">
<colgroup>
<col width="300">
<col width="100">
<col width="100">
<col width="100">
</colgroup>
<tbody>
<tr>
<td data-sheets-value='{"1":2,"2":"Stock purchase rights"}'>Stock purchase rights</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"Green Cross Lab Cell Corp"}' data-sheets-formula="=Terms!R[-5]C[0]">Green Cross Lab Cell Corp</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"Green Cross Cell Corp"}' data-sheets-formula="=Terms!R[-2]C[-1]">Green Cross Cell Corp</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"Note"}'>Note</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"2-month VWAP (May 17~July 15, 2021)"}'>2-month VWAP (May 17~July 15, 2021)</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":101285}'>₩101,285</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":41154}'>₩41,154</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"A"}'>A</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"1-month VWAP (June 16~July 15, 2021)"}'>1-month VWAP (June 16~July 15, 2021)</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":104418}'>₩104,418</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":41268}'>₩41,268</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"B"}'>B</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"1-week VWAP (July 9~July 15, 2021)"}'>1-week VWAP (July 9~July 15, 2021)</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":104029}'>₩104,029</td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":41068}'>₩41,068</td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"C"}'>C</td>
</tr>
<tr>
<td data-sheets-value='{"1":2,"2":"Swap price"}'><strong>Swap price</strong></td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":103244}' data-sheets-formula="=sum(R[-3]C[0]:R[-1]C[0])/3"><strong>₩103,244</strong></td>
<td style="text-align: right;" data-sheets-value='{"1":3,"3":41163.333333333336}' data-sheets-formula="=sum(R[-3]C[0]:R[-1]C[0])/3"><strong>₩41,163</strong></td>
<td style="text-align: right;" data-sheets-value='{"1":2,"2":"(A+B+C)/3"}'><strong>(A+B+C)/3</strong></td>
</tr>
<tr><td colspan="4" rowspan="1" data-sheets-value='{"1":2,"2":"Source: DART &amp; KRX"}'>Source: DART &amp; KRX</td></tr>
</tbody>
</table>

Swap overviewThis merger swap is very similar to the recent case of GS Retail &amp; GS Home Shopping. Green Cross Lab Cell will merge with Green Cross Cell through a stock swap. The Green Cross Cell shareholders will get 0.4023542 Green Cross Lab Cell shares for each Green Cross Cell share.





Swap overview

Type
Stock swap


Acquirer
Green Cross Lab Cell Corp (144510)


Target company
Green Cross Cell Corp (031390)


Swap price for Green Cross Lab Cell
₩102,882


Swap price for Green Cross Cell
₩41,395


Swap ratio
0.4023542

Source: DART

ScheduleThe record date for securing voting rights at the general shareholders' meeting is August 2nd. The last day to secure the purchase right was yesterday. If you have purchased stocks by yesterday, you can exercise your stock purchase right by notifying your dissenting opinion between August 27 and September 13.The exercise period of the stock appraisal right is from September 13th to October 4th. Trading of Green Cross Cell will be suspended from October 28th to November 11th, and new shares of Green Cross Lab Cell will be listed on November 12th.





Schedule

Last day to own stock purchase rights
2020. 07. 19


Record date of the shareholder register
2020. 08. 02


Dissenting opinion notice
2020. 08. 27 ~ 09. 13


Shareholder meeting
2020. 09. 13


Stock purchase right exercise
2020. 09. 13 ~ 10. 04


Trade suspension (only Green Cross Cell)
2020. 10. 28 ~ 11. 11


Listing
2020. 11. 12

Source: DART


Stock purchase rights
The stock purchase cost ceiling is set at ₩150.0B combined for both. The exercise prices are currently 6.31% and 5.91% below the current share prices of GS Retail and GS Home Shopping. 








Spread - stock purchase
Green Cross Lab Cell Corp
Green Cross Cell Corp


Current price
₩110,200
₩43,750


Exercise price
₩103,244
₩41,163


Premium/discount to the current price
-6.31%
-5.91%


Stock purchase ceiling condition
₩150.0B

Source: DART &amp; KRX



Price calculations
Below is the calculation of swap prices and stock purchase rights exercise prices for reference.









Swap prices
Green Cross Lab Cell Corp
Green Cross Cell Corp
Note


1-month VWAP (June 16~July 15, 2021)
₩104,418
₩41,268
A


1-week VWAP (July 9~July 15, 2021)
₩104,029
₩41,068
B


1-day close (July 15, 2021)
₩100,200
₩41,850
C


Swap price
₩102,882
₩41,395
(A+B+C)/3

Source: DART &amp; KRX











Stock purchase rights
Green Cross Lab Cell Corp
Green Cross Cell Corp
Note


2-month VWAP (May 17~July 15, 2021)
₩101,285
₩41,154
A


1-month VWAP (June 16~July 15, 2021)
₩104,418
₩41,268
B


1-week VWAP (July 9~July 15, 2021)
₩104,029
₩41,068
C


Swap price
₩103,244
₩41,163
(A+B+C)/3

Source: DART &amp; KRX



Green Cross Merger Swap Summary & Arb Spread Status

Pan-Asia Index Flows & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Pan-Asia Index Flows & Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

<p>South Korean biopharmaceutical companies <a href="https://www.smartkarma.com/entities/green-cross-cell-corp" target="_blank" data-smartkarma-citation="entities:15811:1" rel="noopener">Green Cross Cell (031390 KS)</a> ("<strong>GC Cell"</strong>) and <a href="https://www.smartkarma.com/entities/green-cross-labcell-corp" target="_blank" data-smartkarma-citation="entities:33237:1" rel="noopener">Green Cross LabCell (144510 KS)</a> (<strong>"GC LabCell"</strong>) <a href="http://www.globalgreencross.com/eng/community/news_view.do?currentPage=0&amp;idx=1345&amp;gubun=0&amp;searchValue=" target="_blank" rel="noopener">announced</a> last Friday they had entered into a definitive merger agreement to combine in an all-stock transaction. Following the completion of the Merger, GC LabCell will be the surviving entity and GC Cell will be the extinct entity. </p><p>The exchange ratio is set at 0.4023542 GC LabCell Shares per GC Cell Share. At present, the companies have a combined market cap of KRW1.7tn (~US$1.5bn). </p><p>The Deal has been approved by the Boards of both companies. The completion of this Transaction is subject to Shareholder Approvals and Regulatory Approvals and the Transaction is expected to close in 4Q 2021. </p><p><em>More below the fold.</em></p><hr><div class="content-remarks"><p><strong>For more information on M&amp;A rules and practices in Korea, please check: </strong><strong><a href="https://www.smartkarma.com/insights/quiddity-korea-m-a-guide-2020" target="_blank" data-smartkarma-citation="insights:39658" rel="noopener">Quiddity Korea M&amp;A Guide 2020</a> </strong></p></div>

South Korean biopharmaceutical companies Green Cross Cell (031390 KS) ("GC Cell") and Green Cross LabCell (144510 KS) ("GC LabCell") announced last Friday they had entered into a definitive merger agreement to combine in an all-stock transaction. Following the completion of the Merger, GC LabCell will be the surviving entity and GC Cell will be the extinct entity. The exchange ratio is set at 0.4023542 GC LabCell Shares per GC Cell Share. At present, the companies have a combined market cap of KRW1.7tn (~US$1.5bn). The Deal has been approved by the Boards of both companies. The completion of this Transaction is subject to Shareholder Approvals and Regulatory Approvals and the Transaction is expected to close in 4Q 2021. More below the fold.For more information on M&amp;A rules and practices in Korea, please check: Quiddity Korea M&amp;A Guide 2020 

GC Cell - GC LabCell: Korean Biopharma Merger Trading Tight

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Cross Asset Strategy

<p>The Korea Exchange announced its KOSDAQ150 and KRX300 indices rebalances today. There were 17 new additions and 17 deletions for KOSDAQ150. </p><p>Most of the stocks that were expected to be included in KOSDAQ 150 were officially included in the rebalance. However there were a few surprises. For example <a href="https://www.smartkarma.com/entities/nanos-co-ltd" target="_blank" data-smartkarma-citation="entities:16796:1" rel="noopener">Nanos Co Ltd (151910 KS),</a>which was one of the stocks that was expected to be included in KOSDAQ150, did not get included in this indext this time. On the other hand, the following stocks including <a href="https://www.smartkarma.com/entities/sang-a-frontec-co-ltd" target="_blank" data-smartkarma-citation="entities:20692:1" rel="noopener">Sang A Frontec (089980 KS)</a>, Novarex (194700 KS(, CIS (222080 KS), MedPacto (215980 KS), <a href="https://www.smartkarma.com/entities/koreacenter-com-co-ltd" target="_blank" data-smartkarma-citation="entities:28329:1" rel="noopener">Koreacenter.com Co Ltd (290510 KS)</a>, and Soulbrain (357780 KS) which were not on the top of the lists of getting selected into the KOSDAQ150 index by the locals, were formally selected be part of the new KOSDAQ150 inclusions.  </p><p>The Korea Exchange also made changes to the KRX300 index. Although the KRX300 index is not currently as important as KOSPI200 and KOSDAQ150 indices, it is increasingly gaining in importance among the local institutional investors. The KRX300 had 33 new additions and 35 deletions. </p>

The Korea Exchange announced its KOSDAQ150 and KRX300 indices rebalances today. There were 17 new additions and 17 deletions for KOSDAQ150. Most of the stocks that were expected to be included in KOSDAQ 150 were officially included in the rebalance. However there were a few surprises. For example Nanos Co Ltd (151910 KS),which was one of the stocks that was expected to be included in KOSDAQ150, did not get included in this indext this time. On the other hand, the following stocks including Sang A Frontec (089980 KS), Novarex (194700 KS(, CIS (222080 KS), MedPacto (215980 KS), Koreacenter.com Co Ltd (290510 KS), and Soulbrain (357780 KS) which were not on the top of the lists of getting selected into the KOSDAQ150 index by the locals, were formally selected be part of the new KOSDAQ150 inclusions.  The Korea Exchange also made changes to the KRX300 index. Although the KRX300 index is not currently as important as KOSPI200 and KOSDAQ150 indices, it is increasingly gaining in importance among the local institutional investors. The KRX300 had 33 new additions and 35 deletions. 

KOSDAQ150 and KRX300 Indices Rebalances (Overlapping Additions & Deletions)

Frontier and emerging markets (Vietnam)

Dylan Waller

Nomadic Equity

Thematic (Sector/Industry)

<p><strong>Introduction to Medisetter</strong></p><p>I had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's healthcare industry. Medisetter is an international online medical travel search and bookings platform offering a one-stop-shop medical travel booking and planning service. Prospective patients can search and compare hospitals and clinics across different countries, receive price quotes, book appointments and also book accommodation, translators and…</p>

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's healthcare industry. Medisetter is an international online medical travel search and bookings platform offering a one-stop-shop medical travel booking and planning service. Prospective patients can search and compare hospitals and clinics across different countries, receive price quotes, book appointments and also book accommodation, translators and…

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

<p>SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a biosimilar maker either. It makes new biomedical products. A majority of Korea's pharmaceutical makers are still generic drug makers. The likes of Celltrion and Samsung Bioepis have emerged as a biosimilar maker. But they are still a few. Biomedical makers are even rarer. Hanmi Pharmaceutical is one of these rare breeds. Now, another biomedical maker…</p>

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a biosimilar maker either. It makes new biomedical products. A majority of Korea's pharmaceutical makers are still generic drug makers. The likes of Celltrion and Samsung Bioepis have emerged as a biosimilar maker. But they are still a few. Biomedical makers are even rarer. Hanmi Pharmaceutical is one of these rare breeds. Now, another biomedical maker…

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

South Korea

Green Cross Cell Corp is a biotechnology company. The Company develops and commercializes bio-products for immunity cell therapy, and operates autologous lymphocyte, cord blood, and tumor cell bank. Green Cross also tests extreme drug resistance assay (EDR).

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Green Cross Cell (031390 KS)

Green Cross Merger Swap Summary & Arb Spread Status

This merger swap is very similar to the recent case of the GS merger swap. So, we are likely to face a rather juicy swap spread opening probably 2...

Sanghyun Park

GC Cell - GC LabCell: Korean Biopharma Merger Trading Tight

South Korean Biopharma companies GC Cell and GC Lab Cell are merging in an all-stock Deal. The companies have a combined market cap of ~US$1.5bn....

Janaghan Jeyakumar, CFA

KOSDAQ150 and KRX300 Indices Rebalances (Overlapping Additions & Deletions)

We highlight the KOSDAQ150 and KRX300 indices rebalances. There are some interesting new names, especially among those that are over lapping in...

Douglas Kim

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Nomadic Equity

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Sanghyun Park

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)